TIGIT and glioblastoma: GBM cells do express several activator ligand for NK receptors, as for example MHC class I polypeptide-related sequence A (MICA) (29) ligand for NKG2D+ present on NK cells, as well as CD155 and CD112 recognized by TIGIT and CD96 receptors (30).